Clinical trials
Lymphoma, Large B-Cell, Diffuse trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Nordic Lymphoma Group | 3 |
| Genmab | 2 |
| GlaxoSmithKline | 1 |
| Incyte Corporation | 1 |
| Janssen Research & Development, LLC | 1 |
| Lymphoma Trials Office | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | 15 |
| Lymphoma, B-Cell | 4 |
| Lymphoma | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Recurrence | 3 |
| Burkitt Lymphoma | 1 |
| Hematologic Neoplasms | 1 |
| Lymphoma, Large-Cell, Immunoblastic | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.